Autopsy report · NCT00054210
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Cause of deathNo reason given
Life of this trial
- Ran for about 1 year 9 months before it stopped.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- CTI BioPharma
- Sponsor type
- Industry
- Conditions
- Lung Cancer
- Interventions
- carboplatin; paclitaxel; paclitaxel poliglumex
- Sites
- 35
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.